|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/04 | |
| A61K 31/506 | |||
| C07D 403/04 | |||
| C07D 239/26 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3022189 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14742326.3 |
| Europos patento paraiškos padavimo data | 2014-07-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2014/052184 |
| Data | 2014-07-17 |
| (87) | Numeris | WO 2015/008073 |
| Data | 2015-01-22 |
| (30) | Numeris | Data | Šalis |
| 201312800 | 2013-07-17 | GB |
| (72) |
CHRISTOPHER, John, Andrew, GB
CONGREVE, Miles, Stuart, GB
AVES, Sarah, Joanne, GB
TEHAN, Benjamin, Gerald, GB
|
| (73) |
Heptares Therapeutics Limited,
BioPark Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX,
GB
|
| (54) | 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS |
| 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS |